Tolperisone
Systematic (IUPAC) name | |
---|---|
2-methyl-1-(4-methylphenyl)-3-(1-piperidyl)propan-1-one
|
|
Clinical data | |
Trade names | Mydocalm and others |
AHFS/Drugs.com | International Drug Names |
Legal status |
|
Routes of administration |
Oral, parenteral |
Pharmacokinetic data | |
Metabolism | Liver, kidney |
Biological half-life | 1st phase: 2 hrs 2nd phase: 12 hrs |
Excretion | Renal |
Identifiers | |
CAS Number | 728-88-1 |
ATC code | M02AX06 (WHO) M03BX04 |
PubChem | CID: 5511 |
UNII | F5EOM0LD8E |
KEGG | D08617 |
ChEMBL | CHEMBL1076211 |
Chemical data | |
Formula | C16H23NO |
Molecular mass | 245.36 g/mol |
|
|
|
|
(what is this?) (verify) |
Tolperisone, a piperidine derivative, is a centrally acting muscle relaxant. Trade names include Biocalm, Muscodol, Mydeton, Mydocalm, Mydoflex, Myolax, Myoxan and Viveo.
Contents
Clinical use
In Tolperisone is indicated for use in the treatment of pathologically increased tone of the cross-striated muscle caused by neurological diseases (damage of the pyramidal tract, multiple sclerosis, myelopathy, encephalomyelitis) and of spastic paralysis and other encephalopathies manifested with muscular dystonia.[1][2]
Other possible uses include:[citation needed]
- Spondylosis
- Spondylarthrosis
- Cervical and lumbar syndromes
- Arthrosis of the large joints
- Obliterating atherosclerosis of the extremity vessels
- Diabetic angiopathy
- Thromboangiitis obliterans
- Raynaud's syndrome
Contraindications and cautions
Manufacturers report that tolperisone should not be used in patients with myasthenia gravis. Only limited data are available regarding the safety in children, youths, during pregnancy and breastfeeding. It is not known whether tolperisone is excreted into mother's milk.[1][2]
Side effects
Adverse effects occur in fewer than 1% of patients and include muscle weakness, headache, arterial hypotension, nausea, vomiting, dyspepsia, and dry mouth. All effects are reversible.[1][2] Allergic reactions occur in fewer than 0.1% of patient and include skin rash, hives, Quincke's edema, and in some cases anaphylactic shock.[1][3][4][5]
Overdose
Excitability has been noted after ingestion of high doses by children.[1] In suicide studies of three isolated cases, it is believed that ingestion of tolperisone was the cause of death.[6]
Interactions
Tolperisone does not have a significant potential for interactions with other pharmaceutical drugs. It cannot be excluded that combination with other centrally acting muscle relaxants, benzodiazepines or non-steroidal anti-inflammatory drugs (NSAIDs) may make a dose reduction necessary in some patients.[1][2]
Mechanism of action
Tolperisone is a centrally acting muscle relaxant that acts at the reticular formation in the brain stem[1] by blocking voltage-gated sodium and calcium channels.[7][8]
Pharmacokinetics
Tolperisone is absorbed nearly completely from the gut and reaches its peak blood plasma concentration after 1.5 hours. It is extensively metabolised in the liver and kidneys. The substance is excreted via the kidneys in two phases; the first with a half-life of two hours, and the second with a half-life of 12 hours.[1]
See also
- Chemically and mechanistically related drugs: eperisone, inaperisone, lanperisone, silperisone
References
- ↑ 1.0 1.1 1.2 1.3 1.4 1.5 1.6 1.7 Lua error in package.lua at line 80: module 'strict' not found.
- ↑ 2.0 2.1 2.2 2.3 Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- Drugs with non-standard legal status
- Chemical articles having calculated molecular weight overwritten
- Articles with changed InChI identifier
- Infobox drug articles without a structure image
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles with unsourced statements from May 2012
- Piperidines
- Muscle relaxants
- Aromatic ketones
- Calcium channel blockers
- Sodium channel blockers